
{
  "Company Overview": {
    "Name": "Achyut Healthcare Ltd",
    "Sector": "Trading",
    "Industry": "Trading",
    "Business Description": "Incorporated in 1996, Achyut Healthcare Ltd is a pharmaceutical trading company dealing in API, Pharmaceutical products, medical devices, etc.  Company is in the manufacturing of pharmaceutical formulations in the forms of Tablets, Capsules, Oral liquid and Injectables.",
    "Market Position": "Information not explicitly available in provided HTML."
  },
  "Financial Metrics": {
    "Market Cap": "₹ 94.0 Cr.",
    "Current Price": "₹ 3.99",
    "High / Low": "₹ 6.25 / ₹ 2.87",
    "Stock P/E": 142,
    "Book Value": "₹ 1.32",
    "Dividend Yield": "0.00 %",
    "ROCE": "3.27 %",
    "ROE": "2.52 %",
    "Face Value": "₹ 1.00",
    "Debt-to-Equity Ratio": "Information not explicitly available in provided HTML." 
  },
  "Performance Trends": {
    "Quarterly Results": {
      "Sales": {
        "Sep 2021": "2.71",
        "Mar 2022": "1.34",
        "Sep 2022": "1.89",
        "Mar 2023": "0.81",
        "Sep 2023": "1.48",
        "Mar 2024": "4.65",
        "Sep 2024": "2.13"
      },
      "Expenses": {
        "Sep 2021": "2.56",
        "Mar 2022": "1.53",
        "Sep 2022": "1.87",
        "Mar 2023": "1.10",
        "Sep 2023": "1.45",
        "Mar 2024": "4.66",
        "Sep 2024": "2.21"
      },
      "Net Profit": {
        "Sep 2021": "0.09",
        "Mar 2022": "-0.05",
        "Sep 2022": "0.24",
        "Mar 2023": "-0.01",
        "Sep 2023": "0.26",
        "Mar 2024": "0.31",
        "Sep 2024": "0.35"
      }
    },
    "Annual Results": {
      "Sales": {
        "Mar 2019": "0.67",
        "Mar 2020": "0.33",
        "Mar 2021": "0.27",
        "Mar 2022": "4.05",
        "Mar 2023": "2.70",
        "Mar 2024": "6.14",
        "TTM": "6.78"
      },
      "Expenses": {
        "Mar 2019": "0.66",
        "Mar 2020": "0.32",
        "Mar 2021": "0.26",
        "Mar 2022": "4.08",
        "Mar 2023": "2.97",
        "Mar 2024": "6.12",
        "TTM": "6.87"
      },
      "Net Profit": {
        "Mar 2019": "-0.01",
        "Mar 2020": "0.01",
        "Mar 2021": "0.01",
        "Mar 2022": "0.04",
        "Mar 2023": "0.23",
        "Mar 2024": "0.57",
        "TTM": "0.66"
      }
    },
    "Balance Sheet Highlights": {
      "Equity Capital": {
        "Mar 2019": "0.25",
        "Mar 2020": "0.25",
        "Mar 2021": "0.25",
        "Mar 2022": "6.74",
        "Mar 2023": "9.35",
        "Mar 2024": "16.83",
        "Sep 2024": "16.83"
      },
      "Total Liabilities": {
        "Mar 2019": "0.24",
        "Mar 2020": "0.27",
        "Mar 2021": "0.50",
        "Mar 2022": "9.94",
        "Mar 2023": "15.34",
        "Mar 2024": "30.95",
        "Sep 2024": "31.93"
      },
      "Total Assets": {
        "Mar 2019": "0.24",
        "Mar 2020": "0.27",
        "Mar 2021": "0.50",
        "Mar 2022": "9.94",
        "Mar 2023": "15.34",
        "Mar 2024": "30.95",
        "Sep 2024": "31.93"
      }
    },
    "Cash Flow Summaries": {
      "Cash from Operating Activity": {
        "Mar 2019": "-0.03",
        "Mar 2020": "-0.02",
        "Mar 2021": "0.01",
        "Mar 2022": "-6.96",
        "Mar 2023": "-0.43",
        "Mar 2024": "-0.36"
      },
      "Net Cash Flow": {
        "Mar 2019": "-0.03",
        "Mar 2020": "-0.02",
        "Mar 2021": "0.01",
        "Mar 2022": "0.24",
        "Mar 2023": "-0.03",
        "Mar 2024": "0.14"
      }
    }
  },
  "Ratios": {
    "Growth Ratios": {
      "Compounded Sales Growth": {
        "10 Years": null,
        "5 Years": "56%",
        "3 Years": "183%",
        "TTM": "196%"
      },
      "Compounded Profit Growth": {
        "10 Years": null,
        "5 Years": "126%",
        "3 Years": "285%",
        "TTM": "164%"
      }
    },
    "Liquidity Ratios": {
      "Debtor Days": {
        "Mar 2019": "54.48",
        "Mar 2020": "188.03",
        "Mar 2021": "378.52",
        "Mar 2022": "18.02",
        "Mar 2023": "36.50",
        "Mar 2024": "24.37"
      },
      "Inventory Days": {
        "Mar 2019": "0.00",
        "Mar 2020": "0.00",
        "Mar 2021": "158.70",
        "Mar 2022": "14.29",
        "Mar 2023": "59.59",
        "Mar 2024": "3.96"
      },
      "Days Payable": {
        "Mar 2019": "380.87",
        "Mar 2020": "41.78",
        "Mar 2021": "55.87",
        "Mar 2022": "9.24"
      },
      "Cash Conversion Cycle": {
        "Mar 2019": "54.48",
        "Mar 2020": "188.03",
        "Mar 2021": "156.34",
        "Mar 2022": "-9.46",
        "Mar 2023": "40.22",
        "Mar 2024": "19.09"
      },
      "Working Capital Days": {
        "Mar 2019": "76.27",
        "Mar 2020": "210.15",
        "Mar 2021": "216.30",
        "Mar 2022": "603.83",
        "Mar 2023": "1257.22",
        "Mar 2024": "1242.43"
      }
    },
    "Profitability Ratios": {
      "ROCE %": {
        "Mar 2019": "9.76%",
        "Mar 2020": "4.35%",
        "Mar 2021": "2.14%",
        "Mar 2022": "2.63%",
        "Mar 2023": "3.27%"
      },
      "ROE": {
        "10 Years": null,
        "5 Years": "2%",
        "3 Years": "2%",
        "Last Year": "3%"
      }
    },
    "Valuation Ratios": {
      "Price to Book": "Information not explicitly available, but implied by Stock is trading at 3.03 times its book value"
    }
  },
  "Peer Comparison": {
    "Peers": [
      {"Name": "Adani Enterp.", "CMP": "2344.95", "P/E": "47.95", "Mar Cap": "270649.61", "Div Yld": "0.06", "NP Qtr": "1989.19", "Qtr Profit Var": "577.60", "Sales Qtr": "22608.07", "Qtr Sales Var": "15.66", "ROCE": "9.87"},
      {"Name": "Vishal Mega Mart", "CMP": "101.19", "P/E": "100.64", "Mar Cap": "45623.73", "Div Yld": "0.00", "NP Qtr": "254.14", "Qtr Profit Var": "5032.51", "Sales Qtr": "19.27", "Qtr Sales Var": "11.36", "ROCE": "11.36"},
      {"Name": "Aegis Logistics", "CMP": "825.80", "P/E": "49.64", "Mar Cap": "28985.58", "Div Yld": "0.79", "NP Qtr": "152.02", "Qtr Profit Var": "-0.80", "Sales Qtr": "1750.42", "Qtr Sales Var": "41.75", "ROCE": "14.74"},
      {"Name": "Cello World", "CMP": "775.65", "P/E": "50.71", "Mar Cap": "17132.95", "Div Yld": "0.19", "NP Qtr": "86.78", "Qtr Profit Var": "2.06", "Sales Qtr": "490.06", "Qtr Sales Var": "0.22", "ROCE": "36.28"},
      {"Name": "Redington", "CMP": "205.68", "P/E": "13.81", "Mar Cap": "16079.54", "Div Yld": "3.01", "NP Qtr": "282.88", "Qtr Profit Var": "-6.78", "Sales Qtr": "24895.56", "Qtr Sales Var": "12.04", "ROCE": "19.46"},
      {"Name": "MMTC", "CMP": "74.30", "P/E": "52.62", "Mar Cap": "11145.00", "Div Yld": "0.00", "NP Qtr": "48.05", "Qtr Profit Var": "-58.86", "Sales Qtr": "1.56", "Qtr Sales Var": "100.74", "ROCE": "9.23"},
      {"Name": "Honasa Consumer", "CMP": "259.70", "P/E": "111.75", "Mar Cap": "8435.68", "Div Yld": "0.00", "NP Qtr": "-14.92", "Qtr Profit Var": "-139.53", "Sales Qtr": "417.48", "Qtr Sales Var": "-9.28", "ROCE": "17.10"}
    ],
    "Median": {
      "CMP": "126.3",
      "P/E": "37.07",
      "Mar Cap": "337.87",
      "Div Yld": "0.0",
      "NP Qtr": "2.61",
      "Qtr Profit Var": "59.15",
      "Sales Qtr": "44.64",
      "Qtr Sales Var": "28.95",
      "ROCE": "9.64"
    }
  },
  "Other Insights": {
    "Pros": "Company is almost debt free.",
    "Cons": [
      "Stock is trading at 3.03 times its book value",
      "Though the company is reporting repeated profits, it is not paying out dividend",
      "Company has a low return on equity of 2.15% over last 3 years."
    ],
    "Disclaimer": "The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.",
    "Shareholding Pattern Notes": "* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards. Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes. Click on the line-items to see the names of individual entities."
  },
  "Corporate Actions": [
    {
      "Date": "11 Dec",
      "Description": "Allotment of 6.73 crore bonus shares in 4:10 ratio."
    },
    {
      "Date": "11 Dec",
      "Description": "Allotment of 6.73 crore bonus equity shares."
    },
    {
      "Date": "22 Nov",
      "Description": "Voting results of Extra Ordinary General Meeting."
    },
    {
      "Date": "22 Nov",
      "Description": "Voting results of Extra Ordinary General Meeting."
    },
    {
      "Date": "20 Nov",
      "Description": "Record Dates For Sub Division Of Shares And Bonus Issue"
    }
  ],
  "Annual Reports": [
    {"Year": 2024, "Source": "bse"},
    {"Year": 2023, "Source": "bse"},
    {"Year": 2022, "Source": "bse"}
  ]
}
